Skip to main content
. 2017 Apr 21;19(9):910–918. doi: 10.1111/jch.13008

Table 1.

Clinical Data According to the Presence of OSA After Standard Antihypertensive Treatment

Variable All Patients (N=95) No OSA (n=43) OSA (n=52) P Value
Age, y 56±10 53±9 59±9 .005
Men, % 44 32.5 53.8 .03
BMI, kg/m2 30.4±5 29±4.7 31.6±4.8 .01
Neck circumference, cm 39.1±4.0 37.7±4.0 40.3±3.6 .002
Waist circumference, cm 101.8±11.2 97.5±10.5 105.3±10.5 <.001
Diabetes, % 24.7 26.1 23.5 .47
Dyslipidemia, % 51.6 52.3 51.0 .52
Current smoking, % 16.1 16.6 15.6 1.0
Hypothyroidism, % 3.2 2.3 4 1.0
Hypertension diagnosis, y 13.4±10 14±11 12.8±9.5 .59
eGFR, mL/min/1.73 m2 85±20 91±19 81±21 .03
Office SBP, mm Hga 153±23 150±22 155±23 .32
Office DBP, mm Hga 96±14 97±13 95±14 .6
Ambulatory BP monitoring
SBP, 24‐h, mm Hga 131±17 129±18 133±16 .24
SBP, wake, mm Hga 135±17 133±17 137±16 .23
SBP, sleep, mm Hga 121±18 117±18 124±17 .1
SBP, nondipping, % 44.7 32.6 55 .02
DBP, 24‐h, mm Hg 81±12 80±12 81±12 .69
DBP, wake, mm Hg 84±12 84±12 84±12 .78
DBP, sleep, mm Hg 71±13 70±13 72±13 .45
DBP, nondipping, % 27.7 30 25,5 .44
Polysomnography data
Total sleep time, min 333.5±77.5 336±74 331.5±81 .78
N1, % 14±8 11±5 16±9 .001
N2, % 52±8 54±8 51±8 .07
N3, % 19±8 20±7 19±8 .42
REM, % 15±6 15±6 15±6 .79
AHI, events per h 22±19 7±5 34±17 <.001
Baseline SpO2, % 97±2 98±2 97±2 .07
Lowest SpO2, % 82±2 87±6 79±8 <.001
Total sleep time SpO2 <90%, % 0.4(0.03–2.7) 0.02(0–0.3) 1.4(0.3–5.5) <.001

Abbreviations: AHI, apnea‐hypopnea index; BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; N1, stage 1 of sleep; N2, stage 2 of sleep; N3, stage 3 of sleep; OSA, obstructive sleep apnea; REM, rapid eye movement; SBP, systolic blood pressure; SpO2, oxyhemoglobin saturation. P values in bold indicate statistical significance. Sleep stages are reported as a percentage of total sleep time.

a

Obtained after 1 month of standardized antihypertensive treatment as described in the methods section.